| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e459b6d9cc66efbd6417c94813588e27 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4245 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4245 |
| filingDate |
2020-03-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2be4e2d9fe7e4309c83fe631c776ba26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7f882203741642aa449b036ad6436696
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_850c1e6578c689ea02fbc00e413cca57 |
| publicationDate |
2020-09-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2020188089-A1 |
| titleOfInvention |
Methods of treating attention deficit hyperactivity disorder using kdm1a inhibitors such as the compound vafidemstat |
| abstract |
Provided herein are methods for treating attention deficit hyperactivity disorder using KDM1A inhibitors, particularly vafidemstat. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11013698-B2 |
| priorityDate |
2019-03-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |